跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,886 条关于
“EWS::FLI1”
全部
1,886
临床试验
1,110
药物
161
机构
13
资讯
602
5个月前
Trabectedin-Irinotecan Combination Shows Promise Against EWS::FLI1 Fusion in Ewing Sarcoma Phase 1/2 Trial
2年前
Actuate Therapeutics' Elraglusib Shows Promise in Relapsed/Refractory Ewing Sarcoma Trial
去年
Elraglusib Granted FDA Rare Pediatric Disease Designation for Ewing Sarcoma
去年
Actuate Therapeutics and Lantern Pharma Collaborate on AI-Driven Elraglusib Development
11个月前
FDA Clears Lirum's LX-101 for Inclusion in RAPID Platform Trial for Rare Pediatric Cancers
5个月前
Lirum Therapeutics' LX-101 Shows Promising Preclinical Activity in Ewing Sarcoma, Advances to RAPID Platform Trial
上个月
Genomic Profiling of High-Risk Pediatric Tumors Reveals Actionable Alterations in Nearly One-Quarter of Patients
3个月前
New Health Risks Emerge as Europe's Drug Market Grows More Complex, EU Agency Warns
去年
Empyrean Therapeutics Acquires TLR-2 Antagonist EMS-312 from Eos Therapies to Advance Cancer Treatment
去年
El Centro Mayor Achieves Complete Response in Kidney Cancer Trial with Novel Immunotherapy Combination
第 1 页,共 61 页
上一页
下一页